# Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME)

> **NCT01202461** · PHASE1 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 41 (estimated)

## Conditions studied

- Diabetic Retinopathy
- Macular Edema

## Interventions

- **PROCEDURE:** Triple therapy of vitrectomy, IVTA and grid/focal laser photocoagulation

## Key facts

- **NCT ID:** NCT01202461
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-08
- **Final completion:** 2010-09
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2010-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202461, "Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01202461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*